EUVIMEDEUVIMED entdecken
Leserbrief

How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?

Hongru Li, Jiayue Zhang, Linxing Shen, Pei Luo

International Journal of Clinical Oncology · 2026-06 · 31 (6) · 1104-1106

DOI: 10.1007/s10147-026-03014-1 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 09.04.2026. Verfasst von Hongru Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture, Tuina and Rehabilitation, Tongxiang Hospital of Traditional Chinese Medicine, No.3218 Qiuhua Road, Wutong Sub-district, To…. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Acupuncture, Tuina and Rehabilitation, Tongxiang Hospital of Traditional Chinese Medicine, No.3218 Qiuhua Road, Wutong Sub-district, Tongxiang, 314500, Zhejiang Province, China.
  • Infectious Disease Prevention and Control Division, Tongxiang Center for Disease Control and Prevention, Jiaxing, 314500, Zhejiang Province, China.
  • Department of Acupuncture, Tuina and Rehabilitation, Tongxiang Hospital of Traditional Chinese Medicine, No.3218 Qiuhua Road, Wutong Sub-district, Tongxiang, 314500, Zhejiang Province, China. m13806705959@163.com.

Zitieren

APA

Li, H., Zhang, J., Shen, L., & Luo, P. (2026). How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?. International Journal of Clinical Oncology, 31(6), 1104-1106. https://doi.org/10.1007/s10147-026-03014-1

Vancouver

Li H, Zhang J, Shen L, Luo P. How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?. International Journal of Clinical Oncology. 2026;31(6):1104-1106. doi:10.1007/s10147-026-03014-1

BibTeX
@article{Li2026,
  author = {Li, Hongru and Zhang, Jiayue and Shen, Linxing and Luo, Pei},
  title = {How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  volume = {31},
  number = {6},
  pages = {1104--1106},
  doi = {10.1007/s10147-026-03014-1}
}
Kostenlos starten →